Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expression of the Genome in Lymphoid Malignancies

NCT00339963 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00339963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00339963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expression of the Genome in Lymphoid Malignancies
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
November 9, 2001
Completion date
Not reported
Enrollment
1,340 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma, leukemia, lymphoma, non-hodgkin, multiple myeloma